Twist Bioscience (TWST) Change in Accured Expenses (2017 - 2026)

Twist Bioscience (TWST) has reported Change in Accured Expenses for 10 consecutive years, with $8.2 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Change in Accured Expenses rose 155.89% year-over-year to $8.2 million; the TTM figure through Mar 2026 stood at $11.0 million (up 511.22% YoY), while the FY2025 annual figure was $6.6 million, down 16.04% from the prior year.
• Change in Accured Expenses advanced to $8.2 million in Q1 2026 per TWST's latest filing, from -$12.4 million in the prior quarter.
• Across five years, Change in Accured Expenses topped out at $11.3 million in Q3 2025 and bottomed at -$12.4 million in Q4 2025.
• Historically, Change in Accured Expenses has averaged $882176.5 across 5 years, with a median of $1.9 million in 2022.
• Annual changes were most pronounced in 2022 — Change in Accured Expenses slumped 3588.24% — and 2024, when it jumped 801.59%.
• Twist Bioscience's Change in Accured Expenses stood at -$1.3 million in 2022, then surged by 331.26% to $2.9 million in 2023, then slumped by 508.62% to -$11.8 million in 2024, then fell by 4.95% to -$12.4 million in 2025, then soared by 165.68% to $8.2 million in 2026.
• Business Quant data shows TWST's Change in Accured Expenses at $8.2 million in Q1 2026, -$12.4 million in Q4 2025, and $11.3 million in Q3 2025.